Attendo AB (publ)
STO:ATT
Attendo AB (publ)?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
45.15
67
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Attendo AB (publ) hold over its rivals?
What risks and challenges
does Attendo AB (publ) face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Attendo AB (publ).
Provide an overview of the primary business activities
of Attendo AB (publ).
What unique competitive advantages
does Attendo AB (publ) hold over its rivals?
What risks and challenges
does Attendo AB (publ) face in the near future?
Summarize the latest earnings call
of Attendo AB (publ).
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Attendo AB (publ).
Provide P/S
for Attendo AB (publ).
Provide P/E
for Attendo AB (publ).
Provide P/OCF
for Attendo AB (publ).
Provide P/FCFE
for Attendo AB (publ).
Provide P/B
for Attendo AB (publ).
Provide EV/S
for Attendo AB (publ).
Provide EV/GP
for Attendo AB (publ).
Provide EV/EBITDA
for Attendo AB (publ).
Provide EV/EBIT
for Attendo AB (publ).
Provide EV/OCF
for Attendo AB (publ).
Provide EV/FCFF
for Attendo AB (publ).
Provide EV/IC
for Attendo AB (publ).
Show me price targets
for Attendo AB (publ) made by professional analysts.
What are the Revenue projections
for Attendo AB (publ)?
How accurate were the past Revenue estimates
for Attendo AB (publ)?
What are the Net Income projections
for Attendo AB (publ)?
How accurate were the past Net Income estimates
for Attendo AB (publ)?
What are the EPS projections
for Attendo AB (publ)?
How accurate were the past EPS estimates
for Attendo AB (publ)?
What are the EBIT projections
for Attendo AB (publ)?
How accurate were the past EBIT estimates
for Attendo AB (publ)?
Compare the revenue forecasts
for Attendo AB (publ) with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Attendo AB (publ) and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Attendo AB (publ) against its competitors.
Analyze the profit margins
(gross, operating, and net) of Attendo AB (publ) compared to its peers.
Compare the P/E ratios
of Attendo AB (publ) against its peers.
Discuss the investment returns and shareholder value creation
comparing Attendo AB (publ) with its peers.
Analyze the financial leverage
of Attendo AB (publ) compared to its main competitors.
Show all profitability ratios
for Attendo AB (publ).
Provide ROE
for Attendo AB (publ).
Provide ROA
for Attendo AB (publ).
Provide ROIC
for Attendo AB (publ).
Provide ROCE
for Attendo AB (publ).
Provide Gross Margin
for Attendo AB (publ).
Provide Operating Margin
for Attendo AB (publ).
Provide Net Margin
for Attendo AB (publ).
Provide FCF Margin
for Attendo AB (publ).
Show all solvency ratios
for Attendo AB (publ).
Provide D/E Ratio
for Attendo AB (publ).
Provide D/A Ratio
for Attendo AB (publ).
Provide Interest Coverage Ratio
for Attendo AB (publ).
Provide Altman Z-Score Ratio
for Attendo AB (publ).
Provide Quick Ratio
for Attendo AB (publ).
Provide Current Ratio
for Attendo AB (publ).
Provide Cash Ratio
for Attendo AB (publ).
What is the historical Revenue growth
over the last 5 years for Attendo AB (publ)?
What is the historical Net Income growth
over the last 5 years for Attendo AB (publ)?
What is the current Free Cash Flow
of Attendo AB (publ)?
Discuss the annual earnings per share (EPS)
trend over the past five years for Attendo AB (publ).
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
SE |
A
|
Attendo AB (publ)
STO:ATT
|
10B SEK | 6.9 | |
US |
![]() |
HCA Healthcare Inc
NYSE:HCA
|
80.4B USD | 8.2 |
|
SA |
![]() |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 35.6 |
|
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
19.6B Zac | 0 |
|
ZA |
N
|
Netcare Ltd
JSE:NTC
|
18.2B Zac | 0 |
|
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
122.3B CNY | 26.2 |
|
IN |
![]() |
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
1.2T INR | 71.1 |
|
US |
![]() |
Tenet Healthcare Corp
NYSE:THC
|
14.2B USD | 5.8 |
|
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
58.7B MYR | 11.7 |
|
BR |
![]() |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
71.8B BRL | 7 |
|
IN |
![]() |
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 36.8 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
SE |
A
|
Attendo AB (publ)
STO:ATT
|
Average EV/EBITDA:
23.3
6.9
|
6%
|
1.2 | |
US |
![]() |
HCA Healthcare Inc
NYSE:HCA
|
8.2
|
6%
|
1.4 |
|
SA |
![]() |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
35.6
|
19%
|
1.9 |
|
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
Not Available |
7%
|
N/A |
|
ZA |
N
|
Netcare Ltd
JSE:NTC
|
Not Available |
19%
|
N/A |
|
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
26.2
|
25%
|
1 |
|
IN |
![]() |
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
71.1
|
33%
|
2.2 |
|
US |
![]() |
Tenet Healthcare Corp
NYSE:THC
|
5.8
|
5%
|
1.2 |
|
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
11.7
|
7%
|
1.7 |
|
BR |
![]() |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
7
|
15%
|
0.5 |
|
IN |
![]() |
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
36.8
|
23%
|
1.6 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.